Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

GC Biopharma and Novelty Nobility sign an R&D agreement to develop therapies for geographic atrophy

fields as well." About GC Biopharma Corp: GC Biopharma Corp. (formerly known as Green Cross Corporation) is a biopharmaceutical company that delivers life-saving and life-sustaining protein therapeutics and vaccines. Headquartered in Yongin, South...

BioCryst shares real-world data highlighting strong adherence and persistence with ORLADEYO® (berotralstat)

BioCryst Pharmaceuticals, Inc. announced new real-world comparative research on the use of oral, once-daily ORLADEYO® (berotralstat) that found high rates of adherence and persistence for ORLADEYO, similar to the rates observed with two other...

Great Bay Bio launches its Intelligent Drug Development Ecosystem

to cell line development, to culture media development and optimization, etc., giving revolutionary changes to biopharmaceutical development, helping customers develop products faster and better. Mr. Kingsley Leung, co-founder and chairman of GBB,...

The U.S. FDA provides positive guidance on the Phase III trial of 64Cu-SAR-bisPSMA for recurrent prostate cancer.

Clarity Pharmaceuticals a clinical stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer. Is pleased to announce it will be commencing a pivotal...

Aileron Therapeutics will present Phase 1b trial data on low-dose LTI-03 for IPF at the 22nd International Colloquium on Lung and Airway Fibrosis

Aileron Therapeutics, Inc. a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications, announced the presentation of two abstracts...

Eisai strengthens its presence in Saudi Arabia by establishing a new pharmaceutical sales subsidiary to enhance its operations in the region

system. Japan-based Eisai Co. has announced that fully-fledged operations and business activities have begun at Eisai Pharmaceuticals Single Person Limited Liability Company (Eisai Saudi Arabia). A pharmaceutical sales subsidiary recently...

Blue Earth Therapeutics shares positive Phase 1 results for Lutetium (177Lu) rhPSMA-10.1 Injection, advancing its clinical development

Blue Earth Therapeutics Ltd, an emerging leader in the development of therapeutic radiopharmaceuticals, today announced further positive developments for its novel investigational radioligand therapies. Enrolment of patients in the Phase 1 trial...

HNSA-5487 reduced IgG by over 95% in a first-in-human trial, showing redosing potential

in the NiceR program is HNSA-5487. About Hansa Biopharma: Hansa Biopharma is a pioneering commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with...

Promega introduces the GloMax® Galaxy Bioluminescence Imager to illuminate protein dynamics in real time

or altering the physiological state. Implementing bioluminescence imaging in a workflow enhances disease modeling and pharmaceutical candidate screening efforts by providing clearer, real-time insights into how cells and proteins behave in...

BioCare collaborates with AeroSafe Global to introduce sustainable cold chain solutions

BioCare, a leader in specialty pharmaceutical distribution, is excited to announce its new partnership with AeroSafe Global, a pioneer in reliable, sustainable cold chain solutions. This collaboration introduces an innovative, reusable...

LenioBio partners with ReciBioPharm to scale up ALiCE® technology and accelerate vaccine production

for new biological modalities encompassing technologies based on live viruses and viral vectors, live-microbial biopharmaceutical products, nucleic acid-based mRNA and plasmid DNA production. Led by a management team and technical experts with a...

Doer Biologics announces the dosing of the first patient in a Phase 2 study of DR10624 for severe hypertriglyceridemia treatment.

Zhejiang Doer Biologics Co., Ltd. a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and cancers, announces that DR10624, its first-in-class (FIC), tri-specific agonist targeting Fibroblast...

Galmed releases Phase 3 Aramchol results in Hepatology.

Galmed Pharmaceuticals Ltd. a clinical-stage biopharmaceutical company for liver, metabolic and fibro-inflammatory diseases announced that the one-year results of the Open-Label part (ARCON ) of its global Phase 3 trial of Aramchol in 150 patients...

EydisBio receives FDA Orphan Drug Designation for its TAK1 inhibitor to treat systemic sclerosis.

and potent, orally bioavailable TAK1 inhibitor for the treatment of systemic sclerosis. EydisBio is an early-stage pharmaceutical company leveraging a novel approach to treating various autoimmune and inflammatory diseases, including rare diseases....

nuBioAge, nuHx, and Marius Pharmaceuticals launch a collaborative GLP-1 comparison study in male patients.

Beach, has announced a partnership between their new comprehensive assessment and research center, nuHx, and Marius Pharmaceuticals, the company behind KYZATREX® (testosterone undecanoate) CIII capsules, an FDA-approved oral testosterone treatment...

Anixa Biosciences has unveiled its Phase 2 study plan for a breast cancer vaccine.

trial advances, providing a faster and more cost-effective path toward potential approval and/or partnerships with pharmaceutical companies. "We are excited to unveil our Phase 2 study plan, bringing us one step closer to a potentially...

Restore Hyper Wellness has partnered with MECOTEC to enhance their offerings in cryotherapy solutions.

first cryo-chamber was built in 1995) to a world leader in high-tech cooling solutions. MECOTEC offers expertise in pharmaceutical and industrial applications as well as electric cryo-chambers for fitness, wellness and sports. The company provides...

2nd Global Summit on Pharmaceutical and Medicinal Chemistry 2024

2nd Global Summit on Pharmaceutical and Medicinal Chemistry (PMC2024), which will be held in Dubai, UAE, during September 23,25, 2024. 2nd Global Summit on Pharmaceutical and Medicinal Chemistry (PMC2024), which will be held in Dubai, UAE, during...

Biotech Congress 2024

such as renewable energy, food, agriculture, health-care, biodegradable polymers, biofertilizers, biopesticides, biopharmaceuticals, commodity and fine chemicals etc.

The American Kidney Fund's Rare Kidney Disease Advocacy Day on Capitol Hill aims to gather support for legislation to boost awareness and treatment of rare kidney diseases.

kidney disease." AKF is grateful to the sponsors of the RKDAN whose support helps make this event possible: Novartis Pharmaceuticals Corporation, Otsuka America Pharmaceutical, Inc. and Travere Therapeutics. About the American Kidney Fund: The...